netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Formulary Chapter 10: Musculoskeletal and joint diseases - Full Section
Notes:

This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net. 

For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
 Useful Links
Link   LSCMMG: Axial Spondyloarthritis: High Cost Drugs Commissioning Pathway
Link   LSCMMG: Gout Management Summary Guidelines
Link   LSCMMG: Juvenile Idiopathic Arthritis in adult patients: Position statement for biological agents
Link   LSCMMG: Psoriatic Arthritis: High Cost Drugs Commissioning Pathway
Link   LSCMMG: Rheumatoid Arthritis: High Cost Drugs Commissioning Pathway
Link   NHS England high cost drugs commissioning list
Link   NICE CG124: Hip fracture: management
Link   NICE NG100: Rheumatoid arthritis in adults: management
Link   NICE NG193: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain
Link   NICE NG219: Gout: diagnosis and management
Link   NICE NG226: Osteoarthritis in over 16s: diagnosis and management
Link   NICE NG38: Fractures (non-complex): assessment and management
Link   NICE NG59: Low back pain and sciatica in over 16s: assessment and management
Link   NICE NG65: Spondyloarthritis in over 16s: diagnosis and management
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
spacespace Rheumatoid arthritis and other inflammatory disorders (0,0)
10.01.01 Non-steroidal anti-inflammatory drugs (10,0)
spacespace Aspirin (0,0)
10.01.02 Corticosteroids (0,0)
10.01.02.01 Systemic corticosteroids (0,0)
10.01.02.02 Local corticosteroids injections (2,0)
10.01.03 Drugs which suppress the rheumatic disease process (0,0)
spacespace Penicillamine (1,0)
spacespace Antimalarials (1,0)
spacespace Drugs affecting the immune response (6,0)
spacespace Cytokine modulators (22,0)
spacespace Sulfasalazine (1,0)
10.01.04 Gout and cytotoxic-induced hyperuricaemia (0,0)
spacespace Acute attacks of gout (1,0)
spacespace Long-term control of gout (3,0)
spacespace Hyperuricaemia associated with cytotoxic drugs (1,0)
10.02 Drugs used in neuromuscular disorders (5,0)
10.02.01 Drugs which enhance neuromuscular transmission (0,0)
spacespace Anticholinesterases (1,0)
spacespace Immunosuppressant therapy (0,0)
10.02.02 Skeletal muscle relaxants (6,0)
spacespace Nocturnal leg cramps (1,0)
10.03 Drugs for the treatment of soft-tissue disorders and topical pain relief (0,0)
spacespace Extravasation (0,0)
10.03.01 Enzymes (1,0)
10.03.02 Rubefacients, topical NSAIDs, capsaicin, and poultices (1,0)
spacespace Topical NSAIDs and counter-irritants (1,0)
spacespace Capsaicin (2,0)
10.04 Dibotermin (1,0)
10.05 Devices (1,0)
netFormulary